Efficacy of Intensification Regimes of Biologic Therapy in Patients With Inflammatory Bowel Disease and Secondary Non-Response: Experience of a Single Referral Centre

被引:0
|
作者
Lukas, Milan
Duricova, Dana
Bortlik, Martin
Machkova, Nadezda
Komarek, Viktor
Bouzkova, Eva
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S591 / S591
页数:1
相关论文
共 50 条
  • [21] DERANGED LIVER FUNCTION TESTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTRE EXPERIENCE
    Sidhu, P. S.
    Mothey, P.
    Wood, J.
    saeed, M.
    Gurung, A.
    Chadha, M.
    Agrawal, A.
    GUT, 2017, 66 : A168 - A168
  • [22] Safety of recombinant zoster vaccine in patients with Inflammatory Bowel Disease: a single centre experience
    Todeschini, A.
    Geccherle, A.
    Signoretto, P.
    Variola, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 756 - 756
  • [23] Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease
    Hindryckx, Pieter
    Novak, Gregor
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (04) : 633 - 641
  • [24] Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Marsal, Jan
    Barreiro-de Acosta, Manuel
    Blumenstein, Irina
    Cappello, Maria
    Bazin, Thomas
    Sebastian, Shaji
    FRONTIERS IN MEDICINE, 2022, 9
  • [25] Common polymorphism in the aldehyde oxidase gene is a marker of non-response to azathioprine therapy in inflammatory bowel disease
    Smith, M. A.
    Marinaki, T.
    Ansari, A.
    Sanderson, J.
    GUT, 2008, 57 : A36 - A36
  • [26] Thromboembolism in paediatric inflammatory bowel disease- A single centre experience
    Cheah, E.
    Fam, W.
    Lee, C.
    Magoffin, A.
    Dutt, S.
    Stormon, M.
    Gaskin, K.
    O'Loughlin, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 192 - 192
  • [27] The use of sirolimus for refractory inflammatory bowel disease: A single centre experience
    Mutalib, M.
    Blackstock, S.
    Chadokufa, S.
    Huggett, B.
    Shah, N.
    Elawad, M.
    Kiparissi, F.
    Lindley, K.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S195 - S195
  • [28] Efficacy and effectiveness of biologic therapy in inflammatory bowel disease. EFIFECT study
    Ginard, Daniel
    Khorrami, Sam
    Perez-Carazo, Leticia
    Tavio-Hernandez, Eduardo
    Lopez-Sanroman, Antonio
    Garcia-Alvarado, Maria
    Munoz, Fernando
    Ibanez-Samaniego, Luis
    Marin-Jimenez, Ignacio
    Guevara, Jorge
    Casellas, Francesc
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (06): : 369 - 376
  • [29] MANAGEMENT OF PRIMARY AND SECONDARY NON-RESPONSE TO B CELL DEPLETION THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS: 10-YEAR EXPERIENCE AT A SINGLE CENTRE
    Yusof, M. Y. Md
    Shaw, D.
    El-Sherbiny, Y.
    Dass, S.
    Rawstron, A. C.
    Vital, E. M.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 338 - 338
  • [30] HISTOPLASMOSIS IN THE SETTING OF BIOLOGIC THERAPY: A TERTIARY CARE INFLAMMATORY BOWEL DISEASE EXPERIENCE
    Sarker, Shabnam
    Law, Michelle E.
    Horst, Sara N.
    Nohl, Anne J.
    Duley, Caroline
    Annis, Kim
    Wiese, Dawn M.
    Schwartz, David A.
    Beaulieu, Dawn
    GASTROENTEROLOGY, 2017, 152 (05) : S579 - S579